About this partner
CardioMech is developing a catheter-based mitral valve repair technology to specifically treat patients suffering from moderate to severe or severe, symptomatic DMR due to prolapse or flail. The CardioMech MVRS technology is designed to provide a fully percutaneous catheter-based therapy for the placement of artificial chord(s) to eliminate MR as an alternative to surgical mitral valve repair. Caution: The CardioMech device is in the early R&D development phase and is NOT approved or cleared by the FDA or any other regulatory body in any region of the world.
In the Know: Healthcare News for January 8, 2024
CardioMech Raises $13M in Heavily Oversubscribed Round for its Transcatheter Mitral Chordal Repair Technology
In the Know: Healthcare News for December 13, 2021
In the Know: Healthcare News for September 8, 2020